Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Abstract: Adverse drug reactions considerably impact patient outcomes and healthcare costs in cancer therapy. Using artificial intelligence to predict adverse drug reactions in real time could ...

1 Faculty of Life Science and Technology & The Affiliated Anning First People’s Hospital, Kunming University of Science and Technology, Kunming, China 2 Faculty of Life Science and Technology, Kunming ...

IDH1 inhibitors show strong efficacy and tolerability in IDH1-mutated AML and MDS, with some patients achieving long-term remissions. Molecular characteristics, such as lower mutational and blast ...

aDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China bDepartment of Gastroenterology, Beijing Friendship Hospital ...

MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively destroy cancer. The cells are designed to suppress immune-rejection signals ...

Use of low-value cancer care after practice acquisition by private equity. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include a full text ...

Introduction: Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare, aggressive malignancy with limited therapeutic options and poor prognosis. Despite immune checkpoint ...